Leading Biotechnology Analyst Geoffrey Porges Joins LEERINK Partners

BOSTON--(BUSINESS WIRE)--LEERINK Partners, a leading healthcare investment bank, announced that Geoffrey Porges has joined its Equity Research team as a Managing Director, Senior Biotechnology Analyst, and Director of Therapeutics Research. Dr. Porges will lead LEERINK’s sector coverage of large cap biotechnology stocks and provide coverage for selected established and emerging biopharmaceutical companies. Dr. Porges will be based in the firm’s New York office.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC